RGC
Regencell Bioscience Holdings Limited$24.17
LiveJun 01, 2026
Market cap
$11.95B
52w range
9.39 – 83.60
P / E
—
EPS
—
Volume
72.92K
Revenue · FY
—
Explain this page
Arphra AIPlain-English read on Regencell Bioscience Holdings Limited’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Peers
No peer list available for RGC.
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.13% | +0.29% | -17.00% | -7.85% | +102.26% | +15.10% | +22.82% | +4138.42% | +8647.10% | +8647.10% | +8647.10% |
Aftermarket
LiveLast trade
$24.63
497 sh
Bid
$24.00
15 sh
Ask
$25.25
10 sh
Spread
$1.250
Sector & industry today
LiveSectors
- Technology+0.67%
- Basic Materials+0.15%
- Communication Services+0.13%
- Real Estate-0.13%
- Industrials-0.48%
- Energy-0.58%
- Healthcare-0.65%
- Financial Services-0.80%
- Consumer Defensive-0.85%
- Consumer Cyclical-0.85%
- Utilities-1.15%
Top industries (issuer's industry highlighted)
- Drug Manufacturers - Specialty & Generic+0.32%
- Computer Hardware+8.35%
- Software - Infrastructure+7.61%
- Coal+5.76%
- Consulting Services+5.28%
- Medical - Healthcare Information Services+5.23%
- Medical - Diagnostics & Research+4.96%
- REIT - Healthcare Facilities-3.49%
- Broadcasting-3.48%
- Software - Application+3.44%
- Advertising Agencies+3.24%
- Biotechnology+3.22%
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Bronstein, Gewirtz & Grossman LLC Urges Regencell Bioscience Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harmfeeds.newsfilecorp.com·May 13, 2026
- Bronstein, Gewirtz & Grossman LLC Urges Regencell Bioscience Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harmglobenewswire.com·May 13, 2026
- RGC CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Deadline on June 23, 2026newsfilecorp.com·May 13, 2026
- RGC DEADLINE: Levi & Korsinsky Reminds Regencell Bioscience Holdings Limited Investors of Upcoming Securities Class Action Deadlineprnewswire.com·May 13, 2026
- ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGCnewsfilecorp.com·May 12, 2026
- ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGCnewsfilecorp.com·May 12, 2026
- ROSEN, LEADING INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action – RGCglobenewswire.com·May 12, 2026
- ROSEN, LEADING INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action – RGCglobenewswire.com·May 12, 2026
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|